Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Van Braeckel

Showing results (21-30 of 71) with videos related to

Pageof 8
Sort By:
Pathogens (Basel, Switzerland)|January 26, 2024
Management Challenges of Extrapulmonary Nontuberculous Mycobacterial Infection: A Single-Center Case Series and Literature ReviewMaja Kiselinova, Leslie Naesens, Diana Huis In 't Veld, et al.
Clinical Pharmacokinetics|August 19, 2020
Pharmacokinetics in Patients with Cystic Fibrosis: A Systematic Review of Data Published Between 1999 and 2019Pieter-Jan De Sutter, Elke Gasthuys, Eva Van Braeckel, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 16, 2018
Establishing the diagnosis of chronic colonization with Pseudomonas aeruginosa of cystic fibrosis patients: Comparison of the European consensus criteria with genotyping of P. aeruginosa isolatesLeander Jonckheere, Petra Schelstraete, Leen Van Simaey, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 1, 2026
Rethinking CFTR variant responsiveness: Differential responses to vanzacaftor and elexacaftorNoelia Rodriguez Mier, Isabelle Callebaut, Marijke Proesmans, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 24, 2022
Altered intravenous drug disposition in people living with cystic fibrosis: A meta-analysis integrating top-down and bottom-up dataPieter-Jan De Sutter, Maxime Van Haeverbeke, Eva Van Braeckel, et al.
Acta Clinica Belgica|August 5, 2024
Expansion of MALDI-TOF MS database as a strategy for identification of <i>Haemophilus</i> species other than <i>H. influenzae</i>Eva Willems, Hannelore Hamerlinck, Anne-Sophie Messiaen, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 6, 2022
Glycemic indices at night measured by CGM are predictive for a lower pulmonary function in adults but not in children with cystic fibrosisDimitri Declercq, Simon Helleputte, Sophie Marchand, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|July 8, 2018
Risk factors and impact of allergic bronchopulmonary aspergillosis in Pseudomonas aeruginosa-negative CF patientsFrans De Baets, Linde De Keyzer, Sabine Van Daele, et al.
In Vivo (Athens, Greece)|March 31, 2005
A safety study of oral tangeretin and xanthohumol administration to laboratory miceBarbara W Vanhoecke, Femke Delporte, Eva Van Braeckel, et al.
Frontiers in Cellular and Infection Microbiology|May 12, 2025
Combinations of posaconazole and tacrolimus are effective against infections with azole-resistant <i>Aspergillus fumigatus</i>Eliane Vanhoffelen, Tine Van Win, Eva Van Braeckel, et al.
Pageof 8

Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
Pathogens (Basel, Switzerland)|January 26, 2024
Management Challenges of Extrapulmonary Nontuberculous Mycobacterial Infection: A Single-Center Case Series and Literature ReviewMaja Kiselinova, Leslie Naesens, Diana Huis In 't Veld, et al.
Clinical Pharmacokinetics|August 19, 2020
Pharmacokinetics in Patients with Cystic Fibrosis: A Systematic Review of Data Published Between 1999 and 2019Pieter-Jan De Sutter, Elke Gasthuys, Eva Van Braeckel, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 16, 2018
Establishing the diagnosis of chronic colonization with Pseudomonas aeruginosa of cystic fibrosis patients: Comparison of the European consensus criteria with genotyping of P. aeruginosa isolatesLeander Jonckheere, Petra Schelstraete, Leen Van Simaey, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 1, 2026
Rethinking CFTR variant responsiveness: Differential responses to vanzacaftor and elexacaftorNoelia Rodriguez Mier, Isabelle Callebaut, Marijke Proesmans, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 24, 2022
Altered intravenous drug disposition in people living with cystic fibrosis: A meta-analysis integrating top-down and bottom-up dataPieter-Jan De Sutter, Maxime Van Haeverbeke, Eva Van Braeckel, et al.
Acta Clinica Belgica|August 5, 2024
Expansion of MALDI-TOF MS database as a strategy for identification of <i>Haemophilus</i> species other than <i>H. influenzae</i>Eva Willems, Hannelore Hamerlinck, Anne-Sophie Messiaen, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 6, 2022
Glycemic indices at night measured by CGM are predictive for a lower pulmonary function in adults but not in children with cystic fibrosisDimitri Declercq, Simon Helleputte, Sophie Marchand, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|July 8, 2018
Risk factors and impact of allergic bronchopulmonary aspergillosis in Pseudomonas aeruginosa-negative CF patientsFrans De Baets, Linde De Keyzer, Sabine Van Daele, et al.
In Vivo (Athens, Greece)|March 31, 2005
A safety study of oral tangeretin and xanthohumol administration to laboratory miceBarbara W Vanhoecke, Femke Delporte, Eva Van Braeckel, et al.
Frontiers in Cellular and Infection Microbiology|May 12, 2025
Combinations of posaconazole and tacrolimus are effective against infections with azole-resistant <i>Aspergillus fumigatus</i>Eliane Vanhoffelen, Tine Van Win, Eva Van Braeckel, et al.
Pageof 8